Clinical Trials Browser

Phase 2/3 × Waiting Lists × 90 days × Clear all

NCT03927885 2026-02-19

Open Labeled Placebo in Reducing Cancer Related Fatigue in Patients With Advanced Cancer

Phase 2/3 Active not recruiting

Neoplasm Metastasis